Top Markets
Coin of the day
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Zhejiang AngLiKang Pharmaceutical CO.,LTD.

Zhejiang AngLiKang Pharmaceutical CO.,LTD.

002940
Kedudukan dalam Saham #11260
Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a company primarily focused on... Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a company primarily focused on the manufacturing and distribution of various pharmaceutical goods. Their operations span the production and sale of active pharmaceutical ingredients (APIs), finished drug formulations, and empty capsules for medical use. The company's existing product line encompasses treatments for a variety of conditions, including anti-infective agents, antihypertensives for blood pressure management, medications for digestive system health, and respiratory preparations. Beyond its current offerings, AngLiKang is also deeply involved in drug research and development. Their R&D efforts are concentrated on creating new therapies, with a particular emphasis on oral cephalosporin antibiotics, as well as treatments for cardiovascular, renal (kidney), and central nervous system diseases. The company was established in 2001 and maintains its headquarters in Shengzhou, China.
Harga Saham
$3.69
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$722.97M
Perubahan (1 hari)
-1.62%
Perubahan (1 tahun)
-46.81%
Negara
CN
Perdagangan Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940)

Kategori

Pendapatan untuk Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Zhejiang AngLiKang Pharmaceutical CO.,LTD., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Zhejiang AngLiKang Pharmaceutical CO.,LTD. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa